13 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:03am
of patients allegedly injured by ACTOS, attorneys’ fees and expenses, and punitive damages. Takeda and Lilly entered into settlement agreements that resolved
6-K
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:05am
, and for medical treatment of patients allegedly injured by ACTOS, attorneys’ fees and expenses, and punitive damages. The court granted Takeda’s motion to dismiss
20FR12B/A
TAK
Takeda Pharmaceutical Co
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
and employees may be injured resulting in loss of business and/or morale, and we may incur costs to remediate possible injury to our customers and employees … on behalf of patients through programs such as Medicaid, and for medical treatment of patients allegedly injured by ACTOS, attorneys’ fees
DRS/A
TAK
Takeda Pharmaceutical Co
16 Nov 18
Draft registration statement (amended)
12:00am
is misappropriated, our reputation with our customers and employees may be injured resulting in loss of business and/or morale, and we may incur … ofACTOS, paid by the states on behalf of patients through programs such as Medicaid, and for medical treatment of patients allegedly injured byACTOS
424B3
s950444w9d7pvtgq5e
14 Nov 19
Prospectus supplement
6:10am
F-4
c2g9l nt2
9 Aug 19
Registration of securities (foreign)
6:27am
F-4/A
l95hzq8ip9j3a07i
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
20FR12B
0jafryywx 5q6wdm
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20-F
otr8cse8 8gfl8yrva0
27 Jun 19
Annual report (foreign)
6:41am
- Prev
- 1
- Next